Total Kidney Volume Measurements in ADPKD by 3D and Ellipsoid Ultrasound in Comparison with Magnetic Resonance Imaging

Visual Abstract Background and objectives Total kidney volume is a validated prognostic biomarker for autosomal dominant polycystic kidney disease. Total kidney volume by magnetic resonance imaging (MRI) and manual segmentation is considered the “reference standard,” but it is time consuming and not readily accessible. By contrast, three-dimensional (3D) ultrasound provides a promising technology for total kidney volume measurements with unknown potential. Here, we report a comparative study of total kidney volume measurements by 3D ultrasound versus the conventional methods by ultrasound ellipsoid and MRI ellipsoid. Design, setting, participants, & measurements This single-center prospective study included 142 patients who completed a standardized 3D ultrasound and MRI. Total kidney volumes by 3D ultrasound and ultrasound ellipsoid were compared with those by MRI. We assessed the agreement of total kidney volume measurements by Bland–Altman plots and misclassification of the Mayo Clinic imaging classes between the different imaging methods, and we assessed prediction of Mayo Clinic imaging classes 1C–1E by average ultrasound kidney length >16.5 cm. Results Compared with MRI manual segmentation, MRI ellipsoid, 3D ultrasound, and ultrasound ellipsoid underestimated total kidney volume (mean difference: −3%, −9%, and −11%, respectively), with Mayo Clinic imaging classes misclassified in 11%, 21%, and 22% of patients, respectively; most misclassified cases by MRI ellipsoid (11 of 16), 3D ultrasound (23 of 30), and ultrasound ellipsoid (26 of 31) were placed into a lower Mayo Clinic imaging class. Predictions of the high-risk Mayo Clinic imaging classes (1C–1E) by MRI ellipsoid, 3D ultrasound, and ultrasound ellipsoid all yielded high positive predictive value (96%, 95%, and 98%, respectively) and specificity (96%, 96%, and 99%, respectively). However, both negative predictive value (90%, 88%, and 95%, respectively) and sensitivity (88%, 85%, and 94%, respectively) were lower for 3D ultrasound and ultrasound ellipsoid compared with MRI ellipsoid. An average ultrasound kidney length >16.5 cm was highly predictive of Mayo Clinic imaging classes 1C–1E only in patients aged ≤45 years. Conclusions Total kidney volume measurements in autosomal dominant polycystic kidney disease by 3D ultrasound and ultrasound ellipsoid displayed similar bias and variability and are less accurate than MRI ellipsoid. Prediction of high-risk Mayo Clinic imaging classes (1C–1E) by all three methods provides high positive predictive value, but ultrasound ellipsoid is simpler to use and more readily available.

[1]  Y. Pei,et al.  Insights into Autosomal Dominant Polycystic Kidney Disease from Genetic Studies. , 2020, Clinical journal of the American Society of Nephrology : CJASN.

[2]  Y. Pei,et al.  Prognostic Performance of Kidney Volume Measurement for Polycystic Kidney Disease: A Comparative Study of Ellipsoid vs. Manual Segmentation , 2019, Scientific Reports.

[3]  D. Landsittel,et al.  Long-term trajectory of kidney function in autosomal-dominant polycystic kidney disease. , 2019, Kidney international.

[4]  A. Levin,et al.  CT of Kidney Volume in Autosomal Dominant Polycystic Kidney Disease: Accuracy, Reproducibility, and Radiation Dose. , 2019, Radiology.

[5]  A. Chapman,et al.  A Practical Guide for Treatment of Rapidly Progressive ADPKD with Tolvaptan. , 2018, Journal of the American Society of Nephrology : JASN.

[6]  A. Paterson,et al.  Prevalence Estimates of Polycystic Kidney and Liver Disease by Population Sequencing. , 2018, Journal of the American Society of Nephrology : JASN.

[7]  F. De Keyzer,et al.  3DUS as an alternative to MRI for measuring renal volume in children with autosomal dominant polycystic kidney disease , 2018, Pediatric Nephrology.

[8]  C. Corsi,et al.  Comparison of Total Kidney Volume Quantification Methods in Autosomal Dominant Polycystic Disease for a Comprehensive Disease Assessment , 2017, American Journal of Nephrology.

[9]  N. Tangri,et al.  Total Kidney Volume as a Biomarker of Disease Progression in Autosomal Dominant Polycystic Kidney Disease , 2017, Canadian journal of kidney health and disease.

[10]  P. McFarlane,et al.  Assessing Risk of Disease Progression and Pharmacological Management of Autosomal Dominant Polycystic Kidney Disease , 2017, Canadian journal of kidney health and disease.

[11]  Vicente E. Torres,et al.  Total Kidney Volume Is a Prognostic Biomarker of Renal Function Decline and Progression to End-Stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease , 2017, Kidney international reports.

[12]  Kaleab Z. Abebe,et al.  Prognostic enrichment design in clinical trials for autosomal dominant polycystic kidney disease: the HALT-PKD clinical trial , 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[13]  Terry K Koo,et al.  A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research. , 2016, Journal Chiropractic Medicine.

[14]  Philip McFarlane,et al.  Total Kidney Volume in Autosomal Dominant Polycystic Kidney Disease: A Biomarker of Disease Progression and Therapeutic Efficacy. , 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[15]  K. Bae,et al.  A comparison of ultrasound and magnetic resonance imaging shows kidney length predicts chronic kidney disease in autosomal dominant polycystic kidney disease , 2015, Kidney international.

[16]  M. Haider,et al.  Imaging-based diagnosis of autosomal dominant polycystic kidney disease. , 2015, Journal of the American Society of Nephrology : JASN.

[17]  Ajay V. Srivastava,et al.  Autosomal dominant polycystic kidney disease. , 2014, American family physician.

[18]  H. G. Guimarães Filho,et al.  Reproducibility of Renal Volume Measurement in Adults Using 3‐Dimensional Sonography , 2014, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[19]  J. Grantham,et al.  Why kidneys fail in autosomal dominant polycystic kidney disease , 2011, Nature Reviews Nephrology.

[20]  G. Leo,et al.  Renal volume assessment with 3D ultrasound , 2011, La radiologia medica.

[21]  J. Grantham,et al.  Clinical practice. Autosomal dominant polycystic kidney disease. , 2008, The New England journal of medicine.

[22]  J. Miller,et al.  Sonographic assessment of the severity and progression of autosomal dominant polycystic kidney disease: the Consortium of Renal Imaging Studies in Polycystic Kidney Disease (CRISP). , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[23]  E E de Lange,et al.  Renal volume measurements: accuracy and repeatability of US compared with that of MR imaging. , 1999, Radiology.

[24]  E E de Lange,et al.  In vitro measurement of kidney size: comparison of ultrasonography and MRI. , 1998, Ultrasound in medicine & biology.

[25]  K. Liang,et al.  Asymptotic Properties of Maximum Likelihood Estimators and Likelihood Ratio Tests under Nonstandard Conditions , 1987 .

[26]  J. Stockman,et al.  A New Equation to Estimate Glomerular Filtration Rate , 2011 .

[27]  A. Paterson,et al.  Unified criteria for ultrasonographic diagnosis of ADPKD. , 2009, Journal of the American Society of Nephrology : JASN.